Abstract
Get full access to this article
View all access options for this article.
References
1.Levofloxacin (systemic) . In: USP DI drug information for the health care professional . 20th ed. Englewood, CO : Micromedex , 2001 . www.nlm.nih.gov/medlineplus/print/druginfo/uspdi/500341.html (accessed 2005 Apr 28).
2.
Naranjo
CA
Busto
U
Sellers
EM
Sandor
P
Ruiz
I
Roberts
EA
. A method for estimating the probability of adverse drug reactions . Clin Pharmacol Ther 1981 ; 30 : 239 –45 .
3.
Tham
TC
Allen
G
Hayes
D
McGrady
B
Riddell
JG
. Possible association between toxic epidermal necrolysis and ciprofloxacin . Lancet 1991 ; 338 : 522 .
4.
Melde
SL
. Ofloxacin: A probable cause of toxic epidermal necrolysis . Ann Pharmacother 2001 ; 35 : 1388 –90 . DOI 10.1345/aph.1Z433
5.
Digwood-Lettieri
S
Reilly
KJ
Haith
LR
Jr
Patton
ML
Guilday
RJ
Cawley
MJ
. Levofloxacin-induced toxic epidermal necrolysis in an elderly patient . Pharmacotherapy 2002 ; 22 : 789 –93 .